There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...

UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $112 and keeps a Buy rating on the shares. Sentiment around Consumer ...

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of $83.00.

(Reuters) - Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $87.67 which represents a slight increase of $0.57 or 0.65% from the prior close of $87.1. The stock opened at $87.21 and touched ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $86.36 which represents a decrease of $-1.10 or -1.26% from the prior close of $87.46. The stock opened at $86.51 and touched a low of ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...

Shares of Colgate-Palmolive Co. CL slipped 1.26% to $86.36 Friday, on what proved to be an all-around grim trading session ...

Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Perrigo Co, Gurrola et al v. Procter & Gamble Co, Harden et al v. Colgate-Palmolive Co, and Gurrola et al v. Chattem Inc, U.S. District Court, Northern District of Illinois, Nos. 25-00348 ...